Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06904222
What this trial is testing

Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection
Guangzhou Patronus Biotech Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT02878330
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 1,453
Not applicableEnded earlyNCT05105191
What this trial is testing

Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room

Who this might be right for
Influenza Viral InfectionsRSV Infection
Erasme University Hospital 280
Early research (Phase 1)Study completedNCT04227210
What this trial is testing

Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 20
Large-scale testing (Phase 3)Study completedNCT03979313
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

Who this might be right for
Respiratory Syncytial Virus Infections
AstraZeneca 3,012
Not applicableStudy completedNCT05964582
What this trial is testing

Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

Who this might be right for
Respiratory Syncytial Virus Infections
Sanofi Pasteur, a Sanofi Company 344
Not applicableStudy completedNCT00593918
What this trial is testing

Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children

Who this might be right for
Respiratory Syncytial Virus Infection
University of Wisconsin, Madison 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT07092865
What this trial is testing

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 168
Early research (Phase 1)Study completedNCT05664334
What this trial is testing

Safety and Immunogenicity of IVX-A12 in Healthy Older Adults

Who this might be right for
Healthy
Icosavax, Inc. 140
Early research (Phase 1)Study completedNCT01852266
What this trial is testing

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableLooking for participantsNCT06881056
What this trial is testing

Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia

Who this might be right for
Respiratory Syncytial Virus (RSV)
West China Second University Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363837
What this trial is testing

Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants

Who this might be right for
Respiratory Syncytial Virus (RSV)
Shanghai Institute Of Biological Products 36
Early research (Phase 1)Study completedNCT02297594
What this trial is testing

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 74
Testing effectiveness (Phase 2)Study completedNCT02266628
What this trial is testing

Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
Novavax 1,599
Large-scale testing (Phase 3)Active Not RecruitingNCT04732871
What this trial is testing

Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,720
Testing effectiveness (Phase 2)Study completedNCT00113490
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children

Who this might be right for
Motavizumab Administration for a Second Season for RSV Prophylaxis
MedImmune LLC 136
Not applicableNot Yet RecruitingNCT07778225
What this trial is testing

Internal Jugular Vein Respiratory Variability as a Marker of Disease Severity in Infant Bronchiolitis

Who this might be right for
Acute BronchiolitisViral BronchiolitisRespiratory Syncytial Virus Infections
Eskisehir Osmangazi University 120
Not applicableUnknownNCT00429637
What this trial is testing

Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients

Who this might be right for
Respiratory Distress Syndrome, AdultRespiratory Syncytial Virus InfectionsPneumonia+1 more
University of Virginia 120
Testing effectiveness (Phase 2)Study completedNCT03258502
What this trial is testing

Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 66
Testing effectiveness (Phase 2)Study completedNCT05639894
What this trial is testing

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 865
Next Page